Provided by Tiger Fintech (Singapore) Pte. Ltd.

Galectin Therapeutics

1.68
-0.0800-4.55%
Post-market: 1.740.0600+3.57%19:36 EDT
Volume:197.19K
Turnover:335.95K
Market Cap:105.44M
PE:-2.31
High:1.79
Open:1.75
Low:1.64
Close:1.76
Loading ...

Top Midday Decliners

MT Newswires
·
21 Dec 2024

Dow Surges 100 Points, Carnival Earnings Top Views

Benzinga
·
20 Dec 2024

Galectin Therapeutics Shares Fall 35.5% After Liver Disease Drug Fails to Meet Main Goal in Study

THOMSON REUTERS
·
20 Dec 2024

BRIEF-Galectin Therapeutics Inc - Belapectin Well Tolerated With No Safety Signals

Reuters
·
20 Dec 2024

Galectin's Belapectin Study Shows Mixed Endpoint Results; Shares Fall Pre-Bell

MT Newswires Live
·
20 Dec 2024

BUZZ-Galectin Therapeutics falls after liver disease drug fails to meet main goal in study

Reuters
·
20 Dec 2024

Galectin Therapeutics Shares Fall 50% Premarket After Liver Disease Drug Fails to Meet Main Goal in Study

THOMSON REUTERS
·
20 Dec 2024

Galectin Therapeutics announces results from NAVIGATE trial on belapectin

TIPRANKS
·
20 Dec 2024

Galectin Therapeutics Inc - Belapectin Did Not Achieve Statistical Significance in ITT Population

THOMSON REUTERS
·
20 Dec 2024

Galectin Therapeutics Announces Top-Line Results of Navigate Clinical Trial Evaluating Belapectin in Patients With Cirrhotic Portal Hypertension Caused by Mash

THOMSON REUTERS
·
20 Dec 2024

Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH

GlobeNewswire
·
20 Dec 2024

Galectin Therapeutics Inc - Belapectin Did Not Achieve Statistical Significance in Intent-to-Treat Population

THOMSON REUTERS
·
20 Dec 2024

Galectin Therapeutics Inc - Belapectin Well Tolerated With No Safety Signals

THOMSON REUTERS
·
20 Dec 2024

Galectin Therapeutics Inc - Belapectin Shows Significant Reduction in Esophageal Varices in 2Mg/Kg Cohort

THOMSON REUTERS
·
20 Dec 2024

Here's Why Galectin Therapeutics (GALT) is Poised for a Turnaround After Losing -31.83% in 4 Weeks

Zacks
·
09 Dec 2024

Galectin Therapeutics presents three abstracts at AASLD 2024 Liver Meeting

TIPRANKS
·
18 Nov 2024